Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer
Clinical trial NCT05969847 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05969847
- Sponsor
- 池畔
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2027-12-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.